SRTA heads into its May 7 earnings report with a notable insider selling cluster — and a 28% one-month stock rally that gave executives plenty of reason to act.
On April 24, four insiders sold shares in a coordinated cluster. President Melissa Tomkiel sold 321,750 shares worth $1.58 million. Co-CEO and CFO William Heyburn sold 301,731 shares for $1.48 million. Both sales followed equity awards granted the day prior on April 23. The combined picture — awards followed immediately by open-market sales — is a textbook pattern of executives managing dilution after a significant price run. The stock had climbed sharply heading into the sales, closing at $5.33 on May 6, up 28% over the prior month.
Short interest softened meaningfully into the report. Shares short dropped about 21% over the past month, falling from roughly 7 million shares to 5.5 million — bringing SI % of Free Float to 6.4%. The borrow market is loose: cost to borrow is just 0.64%, and availability has widened considerably from the 52-week tightest levels seen in March. Back then, utilization of the lending pool reached 53.5%; it has now eased to under 36%. That retreat in short positioning — combined with a 30-day price rally — suggests a meaningful short covering wave has already played out ahead of the print.
Options positioning is mildly defensive but not alarmed. The put/call ratio at 0.21 is modestly above its 20-day average of 0.18, with a z-score of 1.1 — elevated but far from extreme. The 52-week PCR range runs from 0 to 1.93, putting current levels solidly in the cautious-but-not-panicked zone. On the institutional side, ARK Investment Management added 820,064 shares as of April 30 — a notable commitment that backs the recent rally. The EPS surprise factor score ranks in the 89th percentile, meaning the company has a strong history of topping consensus estimates.
The fundamental picture is mixed. Estimated revenue is ~$269 million with EBITDA of ~$30 million, implying an EV/EBITDA multiple around 11.3x. Net income remains negative at an estimated -$9.3 million, though normalized earnings point toward $2.3 million in underlying profitability. The one historical earnings data point available — March 2026 — shows the stock fell 2.3% on the day and 10.4% over the following five sessions. Today's print will test whether a month of short covering and institutional buying has adequately repriced expectations, or whether insiders selling into the rally were a step ahead of the market.
See the live data behind this article on ORTEX.
Open SRTA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
